Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Detecting Circulating Tumor Cells in the Accurate Diagnosis and Treatment of Early Stage Lung Adenocarcinoma

NCT02951897 is registered in ClinicalTrials.gov with Third Military Medical University as lead sponsor.

NCT NCT02951897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02951897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Detecting Circulating Tumor Cells in the Accurate Diagnosis and Treatment of Early Stage Lung Adenocarcinoma
Lead sponsor
Third Military Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2016
Completion date
December 31, 2019
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor cells, diagnoses diseases, lung adenocarcinoma, stage i, treatment